Kepler Cheuvreux’s Elevance Health ELV Stock Holding History

Kepler Cheuvreux’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.75M	Buy	+12,229	New	+$4.88M	0.29%	71

Other funds holding ELV

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Kepler Cheuvreux's ELV Position: Q3 2026 in Review

Kepler Cheuvreux opened a new position in Elevance Health (ELV) in Q3 2026: 12,229 shares worth $4.75M. The stake represents 0.29% of the portfolio and ranks #71 among its holdings.

360 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Kepler Cheuvreux held 12,229 shares of Elevance Health worth $4.75M as of Q3 2026.
Elevance Health was a new Kepler Cheuvreux position in Q3 2026.
Elevance Health made up 0.29% of Kepler Cheuvreux's portfolio in Q3 2026, its #71 holding.
360 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Kepler Cheuvreux's 13F filing for Q3 2026, filed 20 Oct 2026.